Dexcom will present the full data from several studies at the Advanced Technologies and Treatments for Diabetes conference, ...
EDINBURGH, Scotland--(BUSINESS WIRE)-- DexCom, Inc. (Nasdaq: DXCM), a global leader in real-time continuous glucose monitoring for people with diabetes, today announced a significant advancement in ...
DexCom, Inc. (NASDAQ:DXCM), the global leader in glucose biosensing, will present new findings that showcase the benefits of ...
The Stelo is available to anyone who wants to monitor their blood glucose, no prescription needed. But as an active adult ...
Let's consider why this healthcare specialist could be an under-the-radar winner of the GLP-1 boom. Will AI create the ...
DexCom will likely make significant headway in its addressable market in the next five years. The company should also increase its reach by launching new products and entering new countries. Despite a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results